Skip to main content
GRVE logo

Groove Botanicals, Inc. (GRVE) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.007 $0.00 (0.00%)
Vol: 40.0K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Groove Botanicals, Inc. (GRVE) trades at $0.007. Groove Botanicals, Inc. is a Minneapolis-based enterprise, established in 1991, primarily focused on innovating electric vehicle (EV) battery technologies, though it is classified within the Healthcare sector. Sector: Energy.

Price as of · Last analyzed: Jun 15, 2026
Groove Botanicals, Inc. is a Minneapolis-based enterprise, established in 1991, primarily focused on innovating electric vehicle (EV) battery technologies, though it is classified within the Healthcare sector. The company, which previously operated as Avalon Oil & Gas, Inc., trades on the OTC Other tier with limited public disclosures and a market capitalization of $0.00 billion.

Analyst Coverage for GRVE: GRVE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

See all scored stocks →

Groove Botanicals, Inc. (GRVE) Energy Operations & Outlook

CEOKent A. Rodriguez
Employees1
HeadquartersMinneapolis, US
IPO Year2012
SectorEnergy

Groove Botanicals, Inc., founded in 1991 and headquartered in Minneapolis, primarily states a focus on electric vehicle battery technology innovation, despite being classified within the Healthcare sector. Operating on the OTC Other tier, the company evolved from Avalon Oil & Gas, Inc., adopting its current name in 2018.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for GRVE?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Groove Botanicals, Inc. presents a unique investment profile characterized by its stated focus on electric vehicle (EV) battery technologies, juxtaposed with its formal classification within the Healthcare sector as a Drug Manufacturer - Specialty & Generic, and an AI insight suggesting involvement in botanical products. The company's extremely small operational footprint, evidenced by its single employee and $0.00 billion market capitalization, indicates it is either in a very early developmental stage or operates with minimal public presence. Potential value drivers, if any, would stem from significant breakthroughs in EV battery innovation or the successful commercialization of botanical healthcare products, though specific product lines or development timelines are not disclosed. Key risks include the conflicting business descriptions, the illiquidity and limited disclosure associated with its OTC Other listing, and the inherent challenges of competing in highly capital-intensive and regulated industries with minimal resources. Investors face substantial uncertainty regarding the company's actual strategic direction, operational capabilities, and potential for future growth.

Based on FMP financials and quantitative analysis

GRVE Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Market Capitalization of $0.00 billion, indicating a very small or illiquid public entity.

  • Beta of -0.28, suggesting a low correlation with broader market movements, though this can be volatile for micro-cap OTC stocks.
  • Operates with a single employee, reflecting a highly lean or early-stage organizational structure.
  • Does not pay a dividend, consistent with its current operational status and market capitalization.
  • Underwent a significant name change in May 2018 from Avalon Oil & Gas, Inc. to Groove Botanicals, Inc., signaling a strategic pivot.

What Are GRVE's Key Strengths?

Established in 1991, indicating a long corporate history, albeit with significant changes.

  • Stated focus on innovating electric vehicle (EV) battery technologies, a high-growth sector.
  • Potential to capitalize on increasing consumer interest in natural and alternative health products if operating in the botanical sector.
  • Lean operational structure with one employee could imply low overhead costs.

What Are GRVE's Weaknesses?

Conflicting business descriptions (EV battery tech vs. Healthcare/botanical products) create significant ambiguity.

  • Extremely small operational scale with only one employee and a $0.00 billion market capitalization.
  • Limited public disclosure and transparency due to OTC Other tier listing.
  • Unknown disclosure status, indicating a lack of consistent financial reporting.

What Are the Key Risks for GRVE?

Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.

  • Continued ambiguity regarding the company's core business focus (EV battery vs. healthcare/botanical products) could deter investment.
  • High liquidity risk and price volatility due to its OTC Other tier listing and minimal market capitalization.
  • Inability to secure necessary capital or partnerships to develop and commercialize products in highly competitive industries.
  • Operational limitations and lack of scale, evidenced by a single employee, posing challenges for significant R&D or market penetration.
  • Regulatory challenges and compliance costs, particularly if pursuing drug manufacturing or advanced battery technologies.

What Threats Does GRVE Face?

  • Intense competition from well-capitalized and established players in both EV battery and healthcare sectors.
  • Significant regulatory hurdles and capital requirements for product development and commercialization in both industries.
  • High liquidity risk and potential for price volatility due to OTC Other listing and minimal trading volume.
  • Lack of clear strategic focus and operational details could deter potential investors and partners.

What Are GRVE's Competitive Advantages?

  • Specific competitive advantages or 'moats' for Groove Botanicals, Inc. are not discernible from the provided information.
  • The company's stated focus on innovation in EV battery technology or potential involvement in botanical products could imply a reliance on intellectual property, but no details on patents or proprietary technologies are available.
  • Given its single employee and $0.00 billion market capitalization, it is unlikely to possess significant scale, brand recognition, or network effects as competitive advantages.
  • The conflicting business descriptions and lack of operational transparency make it impossible to identify any sustainable competitive edge.

What Does GRVE Do?

Groove Botanicals, Inc., headquartered in Minneapolis, Minnesota, identifies its primary focus as innovating electric vehicle (EV) battery technologies, a sector vital for sustainable transportation and energy storage. The company, established in 1991, underwent a significant transformation in May 2018 when it officially adopted its current name, transitioning from its previous identity as Avalon Oil & Gas, Inc. This historical evolution suggests a pivot from traditional energy sectors. However, despite its stated emphasis on EV battery innovation, Groove Botanicals, Inc. is formally classified within the Healthcare sector, specifically under Drug Manufacturers - Specialty & Generic. Further complicating its public profile, an existing AI insight indicates the company participates in the botanical products sector. This divergence between the company's self-described mission and its industry classification suggests either a strategic shift not fully reflected in public disclosures, or a broad interpretation of its operational scope. With only one employee, the operational capacity to pursue both advanced EV battery research and development and botanical product development within a specialized pharmaceutical context remains a subject requiring further investigation for potential investors seeking clarity on its core business activities and strategic direction. The company's market capitalization is $0.00 billion, reflecting its nascent or highly illiquid status.

What Products and Services Does GRVE Offer?

  • Groove Botanicals, Inc. states its primary business focus is on innovating electric vehicle (EV) battery technologies.
  • The company was established in 1991, indicating a long operational history under different identities.
  • It formally changed its name from Avalon Oil & Gas, Inc. to Groove Botanicals, Inc. in May 2018.
  • The corporate headquarters are located in Minneapolis, Minnesota.
  • Despite its stated EV battery focus, the company is classified within the Healthcare sector.
  • Its industry classification is Drug Manufacturers - Specialty & Generic.
  • An existing AI insight suggests the company also participates in the botanical products sector.
  • The company operates with a single employee, indicating a very lean organizational structure.

How Does GRVE Make Money?

  • The specific business model for Groove Botanicals, Inc. is not publicly detailed, given the conflicting descriptions of its primary focus (EV battery technology vs. botanical products/healthcare).
  • The company's operational scale, with only one employee, suggests either a very early-stage R&D focus or a holding company structure with minimal active operations.
  • The lack of specific product lines or market strategies makes it impossible to define a concrete business model from the available data.

What Industry Does GRVE Operate In?

Groove Botanicals, Inc. presents a complex industry positioning due to conflicting information within its public profile. While the company explicitly states its primary focus is on innovating electric vehicle (EV) battery technologies, it is formally categorized within the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry. Furthermore, an AI insight suggests its participation in the botanical products sector. This creates a dual, and potentially contradictory, market context. If operating within EV battery technologies, the company would contend with a rapidly evolving market driven by global decarbonization efforts and increasing demand for sustainable transportation, facing competition from established automotive giants and specialized battery manufacturers. Conversely, if its operations align with the Healthcare sector and botanical products, it would navigate a market characterized by consumer interest in natural health, regulatory complexities for novel compounds, and competition from both pharmaceutical companies and wellness brands. The lack of specific product lines or market share data for either domain makes a precise competitive assessment challenging, requiring investors to reconcile these disparate industry signals.

Who Are GRVE's Key Customers?

  • Specific customer segments for Groove Botanicals, Inc.
  • If focused on EV battery technology, potential customers could include automotive manufacturers or energy storage solution providers.
  • If operating in the botanical products or healthcare sector, customers might include pharmaceutical companies, health product distributors, or direct consumers, depending on its product offerings.
  • With only one employee and a $0.00 billion market cap, the company's current customer base, if any, is likely minimal or non-existent in terms of commercial scale.
Model self-rating on this text: 57% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

Groove Botanicals, Inc. operates in the Energy sector. It is headquartered in Minneapolis, United States.

ROE 9%

Key Financial Metrics

Return on equity for Groove Botanicals, Inc. stands at 8.7%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -28.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -41.2%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 2/9

Financial Health

Groove Botanicals, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

GRVE Latest News

No recent news available for GRVE.

GRVE Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GRVE.

Price Targets

Wall Street price target analysis for GRVE.

GRVE MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GRVE; grades run from A+ (80-100) to F (below 30).

Leadership: Kent A. Rodriguez

CEO

Kent A. Rodriguez serves as the CEO of Groove Botanicals, Inc. His professional background, including specific educational qualifications, prior executive roles, and career trajectory before joining Groove Botanicals, Inc., is not publicly disclosed. He is noted for managing the company's lean operational structure, which currently consists of one employee.

Track Record: Specific achievements, strategic decisions, or company milestones directly attributable to Mr. Rodriguez's leadership at Groove Botanicals, Inc. are not detailed in the available information. His track record and contributions to the company's evolution, particularly since its rebranding in 2018, require further public disclosure for comprehensive assessment by investors.

GRVE OTC Market Information

Groove Botanicals, Inc. trades on the OTC Other tier, which represents the lowest and most speculative segment of the over-the-counter market. Unlike companies listed on major exchanges like the NYSE or NASDAQ, or even higher OTC tiers such as OTCQX or OTCQB, companies on the OTC Other tier are not required to meet minimum financial standards or file regular reports with the SEC. This tier often includes shell companies, defunct entities, or companies with limited public information, signifying a high-risk environment for investors due to minimal transparency and regulatory oversight. The 'Other' designation implies a significant lack of publicly available information.

  • OTC Tier: OTC Other
Liquidity: The liquidity for GRVE stock is likely extremely low, given its OTC Other tier classification and a reported market capitalization of $0.00 billion. Stocks in this tier typically experience minimal trading volume and wide bid-ask spreads, making it challenging for investors to buy or sell shares efficiently at a fair market price. The difficulty in executing trades can lead to significant price volatility and potential for manipulation. Investors should anticipate substantial illiquidity, meaning converting shares to cash might be difficult and involve significant price concessions.
OTC Risk Factors:
  • Limited public information and transparency due to minimal disclosure requirements on the OTC Other tier.
  • Extremely low trading volume and wide bid-ask spreads, leading to significant liquidity risk and difficulty in executing trades.
  • Increased susceptibility to market manipulation and fraudulent activities due to reduced regulatory oversight.
  • Potential for significant price volatility and difficulty in accurately valuing the company without reliable financial data.
  • Challenges in raising capital and attracting institutional investors due to the speculative nature of OTC Other listings.
Due Diligence Checklist:
  • Verify the company's current operational status and any recent business activities through independent research.
  • Attempt to locate any available financial statements or disclosures, even if not SEC-mandated, to assess financial health.
  • Investigate the background and track record of CEO Kent A. Rodriguez beyond the provided limited information.
  • Seek clarification on the discrepancy between the stated EV battery focus and the Healthcare/botanical products classification.
  • Assess the company's actual employee count and operational infrastructure, beyond the reported single employee.
  • Research any potential legal or regulatory issues the company may have faced.
  • Understand the historical trading patterns and volume to gauge actual market interest and liquidity.
Legitimacy Signals:
  • Established in 1991, indicating a long corporate existence, albeit with a name change.
  • Maintains a corporate headquarters in Minneapolis, Minnesota, suggesting a physical presence.
  • Has a named CEO, Kent A. Rodriguez, providing a point of contact for leadership.
  • Underwent a formal name change in 2018, indicating some level of corporate activity and restructuring.

Common Questions About GRVE (Energy)

What are the implications of GRVE's OTC Other listing for potential investors?

Groove Botanicals, Inc.'s listing on the OTC Other tier signifies several important implications for investors. This tier is typically reserved for companies that do not meet the minimum financial or disclosure requirements of higher OTC tiers or major exchanges like the NYSE or NASDAQ.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Significant conflicting information exists in the source data regarding the company's primary business focus (EV battery technology vs. Healthcare/botanical products). This has been addressed by presenting all conflicting facts as provided.
  • Extremely limited specific operational and financial data available for Groove Botanicals, Inc., leading to reliance on general industry trends for growth opportunities and risks.
  • The company's market capitalization of $0.00 billion and single employee count suggest a highly illiquid, early-stage, or non-operational entity.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

Stock Deep Dives